Feature Channels:

Autoimmune Diseases

Add to Favorites Subscribe Share
fbshare-Autoimmune Diseases

Showing results

110 of 873
image001.png
  • Embargo expired:
    13-Nov-2019 2:00 PM EST

Slowing the Progression of Multiple Sclerosis

Universite de Montreal

By identifying a molecule that delays the progression of MS, researchers pave the way for new therapies for the nearly 77,000 Canadians living with the disease.

Channels: All Journal News, Autoimmune Diseases, Neuro, Pharmaceuticals, Local - Canada, Grant Funded News,

Released:
12-Nov-2019 4:30 PM EST
ACR-Logo-2019 .jpg
  • Embargo expired:
    9-Nov-2019 4:30 PM EST

Limited Availability of Lupus Laboratory Tests, Such As ANA, in Developing Nations Affects Global Usefulness of Criteria and Clinical Trials

American College of Rheumatology (ACR)

According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, supportive laboratory assays to diagnose lupus, specifically the antinuclear antibody (ANA) test, are less often offered in developing nations due to a relative lack of resources.

Channels: Autoimmune Diseases, Clinical Trials, Lupus, Medical Meetings,

Released:
6-Nov-2019 12:00 PM EST
Research Results
ACR-Logo-2019 .jpg
  • Embargo expired:
    9-Nov-2019 4:30 PM EST

Half of People with RA Treated with Immune Checkpoint Inhibitors for Cancer Experience Flare, but Most Able to Continue Treatment

American College of Rheumatology (ACR)

A new study found that cancer patients with a pre-existing autoimmune disease receiving immune checkpoint inhibitors as treatment are likely to experience a flare.

Channels: Arthritis, Autoimmune Diseases, Cancer, Immunology, Medical Meetings,

Released:
6-Nov-2019 12:00 PM EST
Research Results
ACR-Logo-2019 .jpg
  • Embargo expired:
    9-Nov-2019 4:30 PM EST

Live Zoster Vaccine Safe and Effective for People Taking TNF Inhibitors

American College of Rheumatology (ACR)

According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, the live zoster virus vaccine is safe for people who are currently receiving tumor necrosis factor inhibitor (TNFi) biologic therapies for various indications.

Channels: Arthritis, Autoimmune Diseases, Bone Health, Vaccines, Medical Meetings,

Released:
6-Nov-2019 12:00 PM EST
Research Results
ACR-Logo-2019 .jpg
  • Embargo expired:
    9-Nov-2019 4:30 PM EST

Physicians Should Consider Hydroxychloroquine to Reduce the Risk of Recurrent Congenital Heart Block in Subsequent Pregnancies of Women with Anti-SSA/Ro Antibodies

American College of Rheumatology (ACR)

New research findings presented at the 2019 ACR/ARP Annual Meeting discovered that hydroxychloroquine (HCQ) significantly reduces the recurrence rate of congenital heart block in subsequent pregnancies of women with anti-SSA/ Ro antibodies, regardless of their health status.

Channels: Autoimmune Diseases, Cardiovascular Health, Immunology, Liver Disease, Neuro, Children's Health, Medical Meetings,

Released:
6-Nov-2019 12:00 PM EST
Research Results
Newswise: Ultrasound to Guide Treatment Strategy Not Beneficial in Early RA
  • Embargo expired:
    9-Nov-2019 4:30 PM EST

Ultrasound to Guide Treatment Strategy Not Beneficial in Early RA

American College of Rheumatology (ACR)

According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, a treatment strategy guided by ultrasound information use does not appear to provide better treatment decisions in patients with early rheumatoid arthritis.

Channels: Arthritis, Bone Health, All Journal News, Autoimmune Diseases, Medical Meetings,

Released:
6-Nov-2019 12:00 PM EST
Research Results
Newswise: Children with Down Syndrome at Increased Risk for Associated Inflammatory, Erosive Arthritis
  • Embargo expired:
    9-Nov-2019 4:30 PM EST
Released:
6-Nov-2019 12:00 PM EST
Research Results
Newswise: ADA2 is a Sensitive, Specific Biomarker for Life-Threatening Macrophage Activation Syndrome in Systemic JIA
  • Embargo expired:
    9-Nov-2019 4:30 PM EST

ADA2 is a Sensitive, Specific Biomarker for Life-Threatening Macrophage Activation Syndrome in Systemic JIA

American College of Rheumatology (ACR)

According to new research findings presented at the 2019 ACR/ARP Annual Meeting, adenosine deaminase 2 (ADA2) in the peripheral blood is a sensitive, specific biomarker for macrophage activation syndrome, a potentially life-threatening complication of systemic juvenile idiopathic arthritis (systemic JIA)

Channels: All Journal News, Arthritis, Bone Health, Children's Health, Medical Meetings, Autoimmune Diseases,

Released:
6-Nov-2019 12:00 PM EST
Research Results
ACR-Logo-2019 .jpg
  • Embargo expired:
    9-Nov-2019 4:30 PM EST

American College of Rheumatology/Vasculitis Foundation Preview New Draft Recommendations for Vasculitis Treatment at the 2019 ACR/ARP Annual Meeting

American College of Rheumatology (ACR)

The American College of Rheumatology (ACR), in partnership with the Vasculitis Foundation (VF), is previewing new draft recommendations for the treatment of systemic vasculitis at the 2019 ACR/ARP Annual Meeting in Atlanta.

Channels: Arthritis, Autoimmune Diseases, Medical Meetings,

Released:
6-Nov-2019 12:00 PM EST
Research Results
ACR-Logo-2019 .jpg
  • Embargo expired:
    9-Nov-2019 4:30 PM EST

American College of Rheumatology Previews Draft of Updated Gout Treatment Guideline at the 2019 ACR/ARP Annual Meeting

American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) is previewing draft recommendations from an updated treatment guideline for managing patients with gout during the 2019 ACR/ARP Annual Meeting in Atlanta.

Channels: Autoimmune Diseases,

Released:
6-Nov-2019 12:00 PM EST
Feature

Showing results

110 of 873

Chat now!
5.46867